Anti-CD14 Antibody (Atibuclimab)
Catalog No.
F1694
Anti-CD14 Antibody (Atibuclimab)
Featured Products
Atibuclimab is a chimeric monoclonal antibody against CD14, consisting of a mouse variable region and a human IgG4 Fc region. Atibuclimab can be used in the study of amyotrophic lateral sclerosis. Atibuclimab can alleviate LPS-induced symptoms and strongly inhibit LPS-induced pro-inflammatory cytokine release, while only delaying the release of anti-inflammatory cytokines soluble TNF receptor type I and IL-1 receptor antagonist.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.3 kDa
Dry ice
2417175-94-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
IC-14, IC14
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P08571
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CD14, Fc Tag at 2 ug/mL can bind Anti-CD14 Antibody (Atibuclimab)
CD14
Please avoid freeze-thaw cycles.